stomach pain retatrutide for weight loss: Study shows 30% body weight loss STUDY: Novel “Triagonist” Retatrutide Resolved

When people stop the drug, the food noise usually returns, and the weight often follows

Grech O, Mitchell JL, Lyons HS, Yiangou A, Thaller M, Tsermoulas G et al (2024) Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in idiopathic intracranial hypertension

Currently, tirzepatide is indicated for use in patients with type 2 diabetes, but it shows promise as a weight-loss drug as well

GLP-1s are no longer only useful for weight loss and diabetes they are critical for building metabolic resilience and reducing inflammation, making them a powerful component of whole-person, lasting health

There is large inter-person variability in response to GLP1 medications both in terms of weight loss and side effects, with the two potentially being related (that is, people who experience more nausea may lose more weight 30 )

The experience was astounding